Genomics

Bionano frames $90M BioDiscovery buy as way to expand genomics analysis

Bionano Genomics is acquiring genomics software firm BioDiscovery in a $90 million cash and stock deal. While both companies provide genomics analysis solutions, Bionano said combining its technology with BioDiscovery’s software will provide the integrated offering that many labs want.

Oxford Nanopore makes stellar debut on UK stock market

Shares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Exchange yesterday, rising nearly 50% to propel its valuation up towards the £5 billion ($6.7 billion) mark. The Oxford University spinout saw its share price rise from an opening of 425p to 612p by close of trading …

Oxford Nanopore makes stellar debut on UK stock market Read More »

Sensyne, Oxford University deploy AI to find asthma targets

Oxford University and UK clinical artificial intelligence (AI) company Sensyne Health will partner on a project to find new drug targets for people with hard-to-treat asthma. It’s estimated that almost one in five people with asthma find it difficult to control symptoms using current therapies, while around 4% have particularly severe forms that puts them …

Sensyne, Oxford University deploy AI to find asthma targets Read More »

Sema4 goes public via SPAC merger

With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools that combine genomic and clinical data to glean patient care insights, will get $500 million in cash proceeds to grow its business.

Check out video highlights of INVEST Precision Medicine conference from pediatrics to funding trends

The INVEST Precision Medicine conference cast a spotlight on the role of children’s hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.

Nebula Genomics Launches World’s First Genomic NFT – Blockchain

Professor George Church, co-founder of Nebula Genomics and Professor of Genetics at Harvard Medical School What You Should Know: – Professor George Church, co-founder of Nebula Genomics and Professor of Genetics at Harvard Medical School, will be partnering with GRAMMY-nominated, multi-platinum selling artist, producer, entrepreneur, and philanthropist, Akon and his NFT platform, AkoinNFT, to auction …

Nebula Genomics Launches World’s First Genomic NFT – Blockchain Read More »

C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform

– Cancer intelligence company, C2i Genomics announced it has raised $100M in financing from Casdin Capital, NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others. – Funds will be used to accelerate clinical development and commercialization of the company’s C2-Intelligence Platform, a cancer diagnostics service, that uses AI pattern recognition and whole-genome …

C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform Read More »

AWS Launches Next Phase of Diagnostic Development Initiative

What You Should Know: – Today, Amazon Web Services (AWS) launched the next phase of Diagnostic Development Initiative and expanded funding scope. – In the first phase of the initiative, AWS has supported 87 organizations to date through this effort ranging from startups, nonprofits, research institutions, and businesses in 17 countries and awarded $8 million in computing credits and customized expertise from AWS Solutions Architects and the AWS …

AWS Launches Next Phase of Diagnostic Development Initiative Read More »

Data-Driven Future: Impact of Machine Learning on Diabetes Management

Athar Siddiqui:  Global Strategy Lead, Digital Connected Solutions –  Ascensia Diabetes Care “Information technology and business are becoming inextricably interwoven. I don’t think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare.  …

Data-Driven Future: Impact of Machine Learning on Diabetes Management Read More »

What Excites You Most About the Life Sciences Industry in 2021?

We have looked back at some of the biggest advances in 2020, but it’s a new year and time to look ahead, so we asked our Life Sciences team what they are looking forward to in 2021. “Predicting the unknown!” says Thibault Géoui, Senior Director of Discovery Biology & Predictive Risk Management. “We are using …

What Excites You Most About the Life Sciences Industry in 2021? Read More »

Why Cancer Registries are Part of America’s Fight for Racial Equality

Warren A Whyte, Ph.D., VP Scientific Partnerships at ConcertAI According to a 2019 study in the Proceedings of the National Academy of Sciences, one in 1,000 Black males can expect to die at the hands of the police. Black males were also 2.5 times more likely to die during an encounter with police than white …

Why Cancer Registries are Part of America’s Fight for Racial Equality Read More »

Illumina, Sequoia Capital China Launches Genomics Incubator in China

What You Should Know: – Illumina and Sequoia Capital will collaborate to build an ecosystem for life science startup companies advancing breakthrough applications in genomics. – Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina will leverage the expertise of Illumina for Startups in building genomics companies with the unparalleled track record of Illumina …

Illumina, Sequoia Capital China Launches Genomics Incubator in China Read More »

Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease

What You Should Know: – Frenova Renal Research, a global division of Fresenius Medical Care, announced today that it has started to enroll patients in its new endeavor to build the world’s largest genomics registry targeting kidney disease. – The registry will be used to help advance understanding of the genetic drivers of kidney disease and …

Frenova Begins Patient Enrollment to Build World’s Largest Genomics Registry for Kidney Disease Read More »

Meaningful Use of Genomics Requires Informatics Beyond EMRs

Assaf Halevy, Founder and CEO of 2bPrecise Electronic medical records (EMRs) are widely expected to serve as a cornerstone technology that drives the delivery of modern patient care.  But can the EMR alone support all the informatics capabilities required by an ever-evolving healthcare industry? The rapid growth of precision medicine, particularly the use of genetic …

Meaningful Use of Genomics Requires Informatics Beyond EMRs Read More »

UK groups get £12m funding for COVID-19 monitoring software

Researchers at the Wellcome Sanger Institute in the UK are working on software to monitor the genome of SARS-CoV-2 coronavirus in the hope of spotting changes that could affect the fight against COVID-19. Backed by £12.2 million in UK government funding, Wellcome Sanger and the COVID-19 Genomics UK (COG-UK) Consortium intend to develop a real-time …

UK groups get £12m funding for COVID-19 monitoring software Read More »

Nebula Gives Users Ownership Of Their Personal Genomic Data with Oasis Integration

What You Should Know: – Nebula Genomics announces integration with Oasis Labs to give its customers full ownership and control of the data received from their comprehensive genome sequencing tests. – Through Oasis Labs’ unique privacy solution Parcel, Nebula’s users will be able to retain ownership and control of their personal genomic data. Data remains …

Nebula Gives Users Ownership Of Their Personal Genomic Data with Oasis Integration Read More »

$110m financing sets up US, Asia expansion for Sophia Genetics

Swiss medical data specialist Sophia Genetics has raised $110 million in an oversubscribed funding round that will be used to boost its headcount and international presence and prepare to take its shares public. Proceeds from the sixth-round of private fundraising will fund the growth in Asia and the US, where it already operates a subsidiary …

$110m financing sets up US, Asia expansion for Sophia Genetics Read More »

4 Areas Driving AI Adoption in Hospital Operations and Patient Safety

Renee Yao, Global Healthcare AI Startups Lead at NVIDIA COVID-19 has put a tremendous burden on hospitals, and the clinicians, nurses, and medical staff who make them run.  Many hospitals have suffered financially as they did not anticipate the severity of the disease. The extended duration of patient stays in ICUs, the need for more …

4 Areas Driving AI Adoption in Hospital Operations and Patient Safety Read More »

Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics

Shots: Lineagen to receive $9.6M consisting of 6,167,510 shares of Bionano’s common stock, ~ $1.7M in cash and assumption of ~$2.9M in liabilities. The acquisition complements Binano by adding leading cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contracts The acquisition expands Bionano’s Saphyr genome imaging platform by adding Lineagen’s …

Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics Read More »

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform

What You Should Know: – CancerIQ raises $5M in Series A funding led by HealthXVentures to accelerate the growth of its genetic cancer risk assessment platform to identify and manage patients at high risk of cancer. – CancerIQ’s technology enables hospitals to use genomics to personalize the prevention and early detection of cancer. – Two …

CancerIQ Raises $5M to Expand Genetic Cancer Risk Assessment Platform Read More »

Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’

Swiss medical data specialist Sophia Genetics has launched a platform that will sift through data generated at more than 1,000 hospitals around the world to try to work out how the COVID-19 pandemic will evolve in the coming months and years. The data mining tool will be used to try to unearth some of the …

Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’ Read More »

Analysis: July Health IT M&A Activity; Public Company Performance

– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of July 2020. While a pandemic ravages the country, technology valuations are soaring.  The Nasdaq hit an all-time high during the month of July, sailing through the 10,000 mark to post YTD gains …

Analysis: July Health IT M&A Activity; Public Company Performance Read More »

Most hospital, health systems see increase in genomics, genetics vendors by 2023, report finds

The new report, from the University of Pittsburgh Medical Center’s Center for Connected Medicine, surveyed 101 representatives of hospitals and healthcare systems. Nine out of 10 respondents said they were providing genomic or genetic testing or planning to.